RJA
ANIP icon

Raymond James & Associates’s ANI Pharmaceuticals ANIP Stock Holding History

Raymond James & Associates’s Portfolio ANIP Stock Details ANIP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-7,456
Closed -$515K – 3962
2024
Q1 		$515K Buy
+7,456
New +$450K ﹤0.01% 3050
2020
Q1 		– Sell
-3,930
Closed -$242K – 3502
2019
Q4 		$242K Sell
3,930
-833
-17% -$55.2K ﹤0.01% 3226
2019
Q3 		$347K Sell
4,763
-124
-3% -$9.28K ﹤0.01% 2920
2019
Q2 		$402K Sell
4,887
-425
-8% -$30.2K ﹤0.01% 2822
2019
Q1 		$375K Sell
5,312
-9,591
-64% -$564K ﹤0.01% 2852
2018
Q4 		$671K Buy
14,903
+2,998
+25% +$157K ﹤0.01% 2339
2018
Q3 		$673K Buy
11,905
+1,450
+14% +$88.7K ﹤0.01% 2497
2018
Q2 		$698K Sell
10,455
-3,965
-27% -$248K ﹤0.01% 2448
2018
Q1 		$840K Sell
14,420
-7,042
-33% -$447K ﹤0.01% 2259
2017
Q4 		$1.38M Sell
21,462
-1,528
-7% -$95.1K ﹤0.01% 1934
2017
Q3 		$1.21M Buy
22,990
+17,976
+359% +$857K ﹤0.01% 1984
2017
Q2 		$235K Sell
5,014
-354
-7% -$17.1K ﹤0.01% 2886
2017
Q1 		$266K Buy
5,368
+92
+2% +$5.17K ﹤0.01% 2767
2016
Q4 		$320K Buy
5,276
+280
+6% +$17.1K ﹤0.01% 2591
2016
Q3 		$331K Buy
+4,996
New +$312K ﹤0.01% 2554

Other funds holding ANIP

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $10.9B AUM 70.31% 1-Year Est. Return
GACM
Global Alpha Capital Management Montreal, Quebec, Canada $1.67B AUM 35.09% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $33.3B AUM 44.76% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $2.2B AUM 156.35% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Raymond James & Associates's ANIP Position: Q2 2024 in Review

Raymond James & Associates sold out of ANI Pharmaceuticals (ANIP) in Q2 2024, closing a stake of 7,456 shares — an estimated $515K sold.

Raymond James & Associates first reported a position in ANIP in Q3 2016 and held it in 15 quarters. The position peaked at $1.38M in Q4 2017. 201 funds tracked by Wall St. Rank hold ANIP as of Q2 2024.

  • Raymond James & Associates reported no remaining ANI Pharmaceuticals position as of Q2 2024 after selling out during the quarter.
  • Raymond James & Associates sold 7,456 ANI Pharmaceuticals shares in Q2 2024, an estimated $515K.
  • Raymond James & Associates first reported a position in ANI Pharmaceuticals in Q3 2016 and held it in 15 quarters.
  • Raymond James & Associates's ANI Pharmaceuticals position peaked at $1.38M in Q4 2017.
  • 201 funds tracked by Wall St. Rank held ANI Pharmaceuticals as of Q2 2024.

Based on Raymond James & Associates's 13F filing for Q2 2024, filed 19 Jul 2024.